期刊文献+

糖原合成酶激酶3在阿尔茨海默病中的作用 被引量:3

Role of glycogen synthase kinase 3 in Alzheimer's disease
下载PDF
导出
摘要 糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)作为体内主要的蛋白激酶之一,广泛地参与了生长发育、凋亡衰老和肿瘤形成等重大生命过程。GSK-3β-Ser9和GSK-3α-Ser21位点的磷酸化修饰是机体对GSK-3活性调控的关键过程,GSK-3参与了tau蛋白过度磷酸化修饰、β淀粉样蛋白异常聚集和神经元凋亡等过程,因此对GSK-3活性调控的研究是阿尔茨海默病等神经退行性疾病的发病机制和相关治疗研究中的焦点问题之一。 As a key protein kinase in cell,glycogen synthase kinase-3(GSK-3) is widely involved in the life processes such as development,aging,tumor formation,apoptosis and so on.Phosphory-lation of the sites in GSK-3β-Ser9 and GSK-3α-Ser21 is the major mechanism to regulate the GSK-3 activity.It has been shown that GSK-3 participates in the over phosphorylation of tau,abnormal aggregation of Aβ and the apoptosis of neuron,which is closely related to the pathogenesis of Alzheimermer's disease.Therefore,the research on the regulation of GSK-3 activity attracts great attention due to its key role in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
出处 《国际病理科学与临床杂志》 CAS 2010年第3期226-229,共4页 Journal of International Pathology and Clinical Medicine
基金 国家自然科学基金(30700208 30800329)~~
关键词 糖原合成酶激酶3 Ser21/Ser9磷酸化 阿尔茨海默病 glycogen synthase kinase 3 Ser21/Ser9 phosphorylation Alzheimer's disease
  • 相关文献

参考文献19

  • 1Doble BW,Woodgett JR.GSK-3:tricks of the trade for a multi-tasking kinase[J].J Cell Sci,2003,116(7):1175-1186.
  • 2Frame S,Cohen P.GSK3 takes centre stage more than 20 years after its discovery[J].Biochem J,2001,359(1):1-16.
  • 3Jope RS,Yuskaitis CJ,Beural E.Glycogen synthase kinase-3:inflammation,diseases,and therapeutics[J].Neurochem Res,2007,32(4-5):577-595.
  • 4Phiel CJ,Wilson CA,Lee VM,et al.GSK-3α regulates production of Alzheimer's disease amyloid-β peptides[J].Nature,2003,423(6938):435-439.
  • 5Koh SH,Noh MY,Kim SY.Amyloid-beta induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3[J].Brain Res,2008,1188(1):254-262.
  • 6Yu Y,Run XQ,Liang ZH.Developmental regulation of tau phosphorylation,tau kinases and tau phosphatases[J].J Neurochem,2009,108(6):1480-1494.
  • 7Farr GH,Ferkey DM,Yost C,et al.Interaction among GSK-3,GBP,axin,and APC in xenopus axis specification[J].J Cell Biol,2000,148(4):691-702.
  • 8Clevers H.Wnt/β-catenin signaling in development and disease[J].Cell,2006,127(3):469-480.
  • 9Hernandez F,Avila J.The role of glycogen synthase kinase 3 in the early stages of Alzheimer's disease[J].FEBS Lett,2008,582(28):3848-3854.
  • 10Muyllaert D,Kremer A,Jaworski T,et al.Glycogen synthase kinase-3beta or a link between amyloid and tau pathology?[J].Genes Brain Behav,2008,7(1):57-66.

同被引文献23

  • 1刘飞,施建华,丁绍红,尹晓敏.糖元合成酶激酶3β对微管相关蛋白tau的磷酸化作用[J].生物化学与生物物理进展,2007,34(9):945-951. 被引量:12
  • 2Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis [ J ]. Hepatology, 2009,50 (5) : 2022-2033.
  • 3Vincent JL, Sakr Y, Sprung CL, et al. Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study [J]. Crit Care Med, 2006, 34(6) : 344-353.
  • 4Tazi KA, Quioc JJ, Abdel-Razek W, et al. Protein array tech- nology to investigate cytokine production by monocytes from pa- tients with advanced alcoholic cirrhosis: an ex vivo pilot study [ J ]. Hepatol Res, 2009,39 (5) : 706-715.
  • 5Galbois A, Thabut D, Tazi KA, et al. Ex vivo effects of high- density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis [J]. Hepatology, 2009,49 ( 11 ) : 175-184.
  • 6Ohtani M, Nagai S, Kondo S, et al. Mammalian target of ra- pamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendrit- ic cells [J]. Blood, 2008,112(8) :635-643.
  • 7MacAulay K, Doble BW, Patel S, et al. Glycogen synthase ki- nase 3alpha-specific regulation of murine hepatic glycogen metabolism [J]. Cell Metab, 2007,106(9) : 329-337.
  • 8Kumar CC, Madison V. AKT crystal structure and AKT-specific inhibitors [ J ]. Oncogene, 2005,24 ( 3 ) : 7493-7501.
  • 9Brognard J, Sierecki E, Gao T, et al. PHLPP and a second iso- form, PHLPP2, differentially attenuate the amplitude of Akt signalling by regulating distinct Akt isoforms [J]. Mol Cell, 2007,25 ( 5 ) : 917-931.
  • 10Correa F, Mallard C, Nilsson M, et al. Activated microglia de- crease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta [J]. Neurobiol Dis, 2011,4-4(3) : 142-151.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部